Akari Therapeutics (AKTX) Assets (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.24% |
| Dec 31, 2025 | 5.54% |
| Sep 30, 2025 | -10.87% |
| Jun 30, 2025 | -0.09% |
| Mar 31, 2025 | 0.79% |
| Dec 31, 2024 | 1,749.38% |
| Sep 30, 2024 | -46.14% |
| Jun 30, 2024 | 83.12% |
| Mar 31, 2024 | -36.35% |
| Jun 30, 2022 | -41.55% |
| Mar 31, 2022 | -99.95% |
| Dec 31, 2021 | 261,366.49% |
| Sep 30, 2021 | 204.76% |
| Jun 30, 2021 | -38.40% |
| Mar 31, 2021 | 18,676.03% |
| Dec 31, 2020 | -99.70% |
| Sep 30, 2020 | -5.25% |
| Jun 30, 2020 | 49.29% |
| Mar 31, 2020 | 28,195.00% |
| Dec 31, 2019 | -99.67% |
| Sep 30, 2019 | 122.62% |
| Jun 30, 2019 | -43.96% |
| Mar 31, 2019 | -99.98% |
| Dec 31, 2018 | 322,417.26% |
| Sep 30, 2018 | -26.24% |
| Jun 30, 2018 | -32.85% |
| Mar 31, 2018 | -99.96% |
| Dec 31, 2017 | 275,994.61% |
| Sep 30, 2017 | -30.03% |
| Jun 30, 2017 | -12.22% |
| Mar 31, 2017 | -99.95% |
| Dec 31, 2016 | 134,570.09% |
| Sep 30, 2016 | -9.65% |
| Jun 30, 2016 | -8.46% |
| Mar 31, 2016 | -99.93% |
| Dec 31, 2015 | 117,870.34% |
| Sep 30, 2015 | 2,574.80% |
| Jun 30, 2015 | -31.43% |
| Mar 31, 2015 | 27.17% |